News | September 10, 2024
Presence of Mpox virus of West African clade 2 confirmed in isolated patient
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Objective response rate of 54.8% seen with Daiichi Sankyo and Merck’s ifinatamab deruxtecan at 12 mg/kg dose in pretreated patients
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Effective, holistic, science-backed targeted solutions for symptomatic treatment
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Subscribe To Our Newsletter & Stay Updated
